Industry News

Latest orthopaedic industry news on orthopaedic companies, devices, implants & technology trends.

VANCOUVER, BC--(Marketwired - September 01, 2015) - According to a new report on the European markets for spinal implants and vertebral compression fracture (VCF) by iData Research (www.idataresearch.com), the EUR168 million European VCF device market will experience growing procedural volume driven by an elderly population suffering from osteoporosis and the popularization of percutaneous vertebral augmentation (PVA) treatment. PVA is characterized by a high average selling price (ASP) and is anticipated to grow at an accelerating rate. This market includes Medtronic's kyphoplasty and newer cavity creating and height restoring PVA techniques. "The ASP per procedure can vary significantly depending on the products used and how many levels are treated," explains Dr.

Read more ...

Mission Viejo, California – The $9.17 billion global market for cervical fusion, thoracolumbar Implants, MIS spine fusion, interbody fusion, and orthobiologics has evolved dramatically during the last several decades. This is a result of significant advances in the understanding of spinal biomechanics, the proliferation of sophisticated spinal instrumentation devices, surgical advances in bone fusion techniques, refinement of anterior approaches to the spine and the emergence and development of microsurgical, minimally invasive methods and robotics. Because of these advances, it is now possible to stabilize every segment of the spine successfully, regardless of the offending pathology. The global market for spine surgery devices is detailed in the MedMarket Diligence report, “Global Market for Medical Device Technologies in Spine Surgery, 2014-2021.

Read more ...

Access Report: China Orthopedic Power Tools Industry 2015 Market Research Report The China Orthopedic Power Tools Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Orthopedic Power Tools industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Orthopedic Power Tools market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

Read more ...

The Report Japan Orthopedic Prosthetics Industry 2015 Market Research Report provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz This press release was orginally distributed by SBWire Albany, NY -- (SBWIRE) -- 08/28/2015 -- The Japan Orthopedic Prosthetics Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Orthopedic Prosthetics industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Orthopedic Prosthetics market analysis is provided for the Japan markets including development trends, competitive landscape analysis, and key regions development status.

Read more ...

The Report United States Orthopedic Prosthetics Industry 2015 Market Research Report provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz This press release was orginally distributed by SBWire Albany, NY -- (SBWIRE) -- 08/28/2015 -- The United States Orthopedic Prosthetics Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Orthopedic Prosthetics industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Orthopedic Prosthetics market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Read more ...

Recent research into the Global orthopedic power tools industry in 2015 illuminated by new report Tweet Details WhaTech Channel: Medical Market Research Reports Published on Thursday, 27 August 2015 23:49 Submitted by Pawan Kumar WhaTech Agency News from: Big Market Research - Market Research Reports Page views: 2 times The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.

Read more ...

We are excited to announce the opening of a brand new state-of-the-art bioskills in Boston - Boston Bioskills Lab.

Read more ...

Kleinostheim, 05.12.2012 – curasan AG, listed on the General Standard (ISIN: DE 000 549 453 8), has introduced its new bone regeneration material CERASORB® Ortho Paste to the German and European markets at the beginning of December. CERASORB® Ortho Paste is comprised of fine granules of the proven, fully resorbable, synthetic material CERASORB® M Ortho suspended in a hyaluronic acid hydrogel-matrix. The paste-like product has the advantage that it is pre-packaged in a single-use syringe and does not require any mixing or complicated preparation in order to be applied to the bone defect.

Read more ...

Results from a pre-specified pooled analysis of the RECORD clinical trial program confirmed that the novel oral anticoagulant Xarelto® (rivaroxaban), taken as one tablet, once-daily, was superior to enoxaparin-based treatment regimens for the prevention of venous thromboembolism (VTE) after total knee or hip replacement surgery with low rates of major bleeding that were not statistically different from the comparator.

Read more ...

Health Canada has just approved Xarelto® (rivaroxaban) for the prevention of venous thromboembolic events (VTE) in patients who have undergone elective total hip or total knee replacement surgery. This marks the first approval for Xarelto worldwide. For the first time in the world, the new oral, once-daily anticoagulant Xarelto is to be made commercially available to patients in Canada In July 2008, the CHMP issued a positive opinion and recommended approval of rivaroxaban in the EU for the prevention of venous blood clots in patients undergoing elective total hip or total knee replacement surgery. A final decision is expected very soon Xarelto is the most studied oral, direct Factor Xa inhibitor in the world today Xarelto is being jointly developed by Bayer HealthCare and Johnson & Johnson Pharmaceutical Research & Development, L.L.C.  

Read more ...

Submit Community Content

If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!